ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 116

Arthritis as First Presenting Symptom of Inflammatory Bowel Disease: A Case Control Study

Kathryn Phillippi1, Thomas Sferra2, Nora Singer3 and Elizabeth Brooks4, 1Pediatric Infectious Diseases and Rheumatology, Rainbow Babies and Children’s Hospital / Case Medical Center, Cleveland, OH, 2Pediatric Gastroenterology, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH, 3MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio, Cleveland, OH, 4Division of Pediatric Infectious Diseases and Rheumatology, Rainbow Babies and Children’s Hospital / Case Medical Center, Cleveland, OH, Cleveland, OH

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: C-reactive protein (CRP), Case-based, inflammatory bowel disease (IBD), juvenile idiopathic arthritis (JIA) and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:

Inflammatory bowel disease (IBD) is associated with extra-intestinal manifestations, the most common of which is arthralgia/arthritis. 4.1- 15% of patients with inflammatory bowel disease have arthritis1. There has been little to no published research indicating how frequently arthritis is the presenting manifestation of IBD. We performed a case-control study to investigate whether differences exist in initial laboratory values and body measurements in patients with arthritis who are ultimately diagnosed with IBD-associated arthritis compared to patients with juvenile idiopathic arthritis (JIA) without IBD.

Methods:

A retrospective review of children who presented to University Hospitals Rainbow Babies and Children’s Hospital (UH RB&C) pediatric rheumatology clinic between 2010 and 2015 was performed. Children were identified who presented with arthritis without overt gastrointestinal symptoms and who were subsequently diagnosed with IBD. Age and gender matched controls were identified from children with oligoarticular or polyarticular JIA who were seen in the pediatric rheumatology clinic during the same time period. Controls and cases were matched at a 2:1 ratio. Body morphometrics (weight and height) and laboratory results (hemoglobin, platelet count, erythrocyte sedimentation rate, C-reactive protein, and serum albumin) were obtained at their first pediatric rheumatology visit. In all cases, the diagnosis of IBD was confirmed by endoscopy/colonoscopy with intestinal biopsy. Statistical analysis was performed using R software. The univariate analyses were obtained for all variables and if significant (p-value < 0.05) these variables were then included in the logistic regression.

Results:

We identified 12 patients who presented with arthritis and were subsequently diagnosed with IBD. Using the univariate analysis, patients with IBD associated arthritis had significantly lower weight, hemoglobin, albumin and total protein as well as higher CRP and ESR values. Compared to age and gender matched controls (n = 24), patients with IBD-associated arthritis were significantly more likely to have a lower weight percentile and lower albumin levels as compared to patients with JIA without IBD using odds ratios (OR=0.54, 0.023). Performing the multi-variate analysis showed that patients with IBD associated arthritis had significantly elevated CRP and lower weight (p-value= 0.034).

Conclusion:

These data suggest that in patients presenting with arthritis with elevated C-reactive protein in association with lower weight percentile (less than the 25th percentile), IBD should be excluded as the cause for arthritis.


Disclosure: K. Phillippi, 2; T. Sferra, None; N. Singer, None; E. Brooks, None.

To cite this abstract in AMA style:

Phillippi K, Sferra T, Singer N, Brooks E. Arthritis as First Presenting Symptom of Inflammatory Bowel Disease: A Case Control Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/arthritis-as-first-presenting-symptom-of-inflammatory-bowel-disease-a-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/arthritis-as-first-presenting-symptom-of-inflammatory-bowel-disease-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology